Ironwood Pharmaceuticals
(NASDAQ) IRWD
Ironwood Pharmaceuticals Financials at a Glance
Market Cap
$513.63M
Revenue (TTM)
$296.15M
Net Income (TTM)
$24.02M
EPS (TTM)
$0.12
P/E Ratio
26.14
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Price
$3.16
Volume
1,146,030
Open
$3.13
Price
$3.16
Volume
1,146,030
Open
$3.13
Previous Close
$3.15
Daily Range
$3.13 - $3.25
52-Week Range
$0.53 - $5.78
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Price
$3.16
Volume
1,146,030
Open
$3.13
Previous Close
$3.15
Daily Range
$3.13 - $3.25
52-Week Range
$0.53 - $5.78
IRWD News
3 Great Stocks Under $10
IRWD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ironwood Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
100
CEO
Thomas A. McCourt
Website
www.ironwoodpharma.comHeadquarters
Boston, MA 02110, US
IRWD Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
33%
Net Income Margin
8%
Return on Equity
0%
Return on Capital
64%
Return on Assets
6%
Earnings Yield
3.83%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$513.63M
Shares Outstanding
163.06M
Volume
1.15M
Short Interest
0.00%
Avg. Volume
4.69M
Financials (TTM)
Gross Profit
$294.27M
Operating Income
$118.76M
EBITDA
$104.65M
Operating Cash Flow
$127.04M
Capital Expenditure
$34.00K
Free Cash Flow
$127.01M
Cash & ST Invst.
$215.46M
Total Debt
$597.80M
Ironwood Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$47.71M
-47.3%
Gross Profit
$47.25M
-47.8%
Gross Margin
99.04%
N/A
Market Cap
$513.63M
N/A
Market Cap/Employee
$2.03M
N/A
Employees
253
N/A
Net Income
$2.28M
-200.9%
EBITDA
$8.80M
-73.6%
Quarterly Fundamentals
Net Cash
$382.35M
+25.2%
Accounts Receivable
$46.74M
-42.9%
Inventory
$0.00
N/A
Long Term Debt
$394.87M
-33.8%
Short Term Debt
$202.93M
+6263.5%
Return on Assets
6.05%
N/A
Return on Invested Capital
63.52%
N/A
Free Cash Flow
$74.58M
+390.2%
Operating Cash Flow
$74.58M
+390.2%